NASDAQ · BDRX
Biodexa Pharmaceuticals PLC
Follow BDRX
Get an email when an officer or director makes an open-market buy or sale of BDRX. Free. Routine grants and planned sales are left out.
Smart money pulse
What insiders and funds are doing
- infoNo real insider sales in 12 months. Planned 10b5-1 sales and tax withholding are left out.
−100 means everyone selling, +100 everyone buying. This is data, not advice.
How the Pulse works
Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.
Who owns it
8 funds report owning BDRX, same as the quarter before
Insider trades · last 12 months
Real buys and sales
No insider filings loaded for the last 12 months.
Top holders
Biggest funds in BDRX
| Fund | Value | Change |
|---|---|---|
| Armistice Capital, LLC | $43.1K | −24% |
| Gamma Investing LLC | $3.5K | −56% |
| Allied Private Wealth LLC | $1.27K | New |
| SBI Securities Co., Ltd. | $84 | −4% |
| UBS Group AG | $73 | −2% |
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.